Healthy Women Image

Alex Fulton

Alex Fulton has been working in the wellness field for more than 20 years. She has written extensively about integrative medicine, herbalism, supplements and other topics related to holistic health. Alex also focuses on issues related to women's health, from menstruation to menopause. She has collaborated with physicians, midwives and functional medicine practitioners to promote natural approaches to health care for women. She has a BA in English from the University of Wisconsin-Madison.

Full Bio
Female Doctor Palpating Neck of Senior Woman
iStock.com/SeventyFour

Clinically Speaking: Questions to Ask Your Healthcare Provider About Head and Neck Cancer

If you've received a head and neck cancer diagnosis, here are some important questions to ask your healthcare provider.

Created With Support

If you've recently received a diagnosis of head and neck cancer, you may be feeling overwhelmed and unsure about what to do next. HealthyWomen asked Eleni Rettig, M.D., a head and neck surgeon at Brigham and Women's Hospital and Dana-Farber Cancer Institute at Harvard Medical School, to suggest questions you should ask your healthcare provider about head and neck cancer.

What type of head and neck cancer do I have?

Why this question is important:

There are a number of types of head and neck cancer, including those in the throat, voice box, mouth and lips. It's important to understand which type of cancer you have because each one has unique considerations for treatment and prognosis and may be managed by different teams of specialists.

Is this cancer hereditary?

Why this question is important:

While some head and neck cancers may have a genetic component, very few of them are hereditary. It's important to know whether your cancer is hereditary so you can determine whether your family members may also be at risk and whether you should get additional testing.

Was my cancer caused by HPV?

Why this questions is important:

Rettig said people with cancer of the oropharynx, which includes the tonsils and back of the tongue, need to know whether their cancer is caused by the human papillomavirus, or HPV. "HPV-positive oropharynx cancers have a better prognosis than HPV-negative cancers," Rettig said.

Will my treatment be specific to my HPV status?

Why this question is important:

Right now the treatment for oropharynx cancer is the same regardless of HPV tumor status, but there are many clinical trials underway to determine whether HPV-positive oropharynx can be safely managed with less treatment than what is given for HPV-negative cancers.

What are my treatment options?

Why this question is important:

Treatment options — which include surgery, radiation and chemotherapy — are different for each person and are based on factors such as their individual health, what type of tumor they have and what stage the cancer is in.

New ways of treating head and neck cancer are also being studied; these include precision medicine, where a treatment is specifically designed for a person's cancer, and immunotherapy, which activates the immune system to target cancer cells.

What are the side effects of treatment?

Why this question is important:

Side effects of head and neck cancer are very different for each patient, so it's important to ask your doctors what to expect in your particular situation.

"Depending on which treatment you have, side effects and their effect on your quality of life can range from minimal to severe. If you have extensive surgery and/or radiation, you may experience changes in your speech, swallowing and even appearance," Rettig said.

What is the survival rate of this cancer?

Why this question is important:

Factors that affect survival of head and neck cancer include the type of cancer, stage of the disease and, for oropharynx cancers, the HPV status of the tumor.

"Asking about average survival rates can give you a general sense for your prognosis, but it is also important to remember that each patient's experience is unique," Rettig said.

If I haven’t been vaccinated already, should I still consider the HPV vaccine after diagnosis or treatment?

Why this question is important:

The HPV vaccine available in the United States protects against nine types of HPV infection. If you've already been treated for HPV-positive cancer, getting the vaccine will not have an effect on the course of that particular cancer. However, it could protect you against a new infection from other types of HPV that you haven't been exposed to yet.

What specialists do I need to contact?

Why this question is important:

Rettig suggested asking your doctor to recommend a head and neck oncology practice, which typically includes a surgeon, radiation oncologist and medical oncologist. Finding the right specialists is important because they have specialized knowledge and are better equipped to meet your specific treatment needs.

What support services and resources are available to me and my loved ones?

Why this question is important:

Since caring for a loved one with cancer can be emotionally and physically draining, friends and family who will be helping you through your treatment may want to seek out a support group for caregivers.

Rettig pointed to Support for People with Oral and Head and Neck Cancer, a national support organization, and the American Head & Neck Society as great sources of support and information.

This resource was created with support from Merck.

You might be interested in
Trending Topics

Español

November is Stomach Cancer Awareness Month.

If gastroesophageal cancer sounds complex — it is.

Gastroesophageal cancer is the broad term for cancer involving the esophagus and/or stomach.

Unfortunately, these cancers are often diagnosed in advanced stages because early-stage symptoms like reflux or heartburn are ignored or dismissed as part of everyday life. And there’s no routine screening for gastroesophageal cancer.

But knowing the risk factors and what to look for can help catch the cancer in early stages when it’s most treatable.

Here’s what you need to know about gastroesophageal cancer.

What is gastroesophageal cancer?

Gastroesophageal cancer is cancer involving the esophagus, the gastroesophageal junction (where your food pipe connects to your stomach) and the stomach.

The most common type of gastroesophageal cancer is gastroesophageal adenocarcinoma (GEA).

Risk factors for gastroesophageal cancer

Long-term irritation of the esophagus and stomach is a common risk factor for gastroesophageal cancer.

Other risk factors can include:

  • A diet high in meat, hot beverages and/or smoked foods
  • Smoking
  • Alcohol use
  • Obesity
  • Being over age 55
  • A history of gastroesophageal reflux disease (GERD)
  • A history of Barrett’s esophagus
  • A history of Helicobacter pylori (H. pylori) infection
  • Family history of esophageal cancer and other types of cancer

What are the symptoms of gastroesophageal cancer?

Symptoms of gastroesophageal cancer are often mild or nonexistent in early stages and become more noticeable as the disease progresses.

Symptoms of gastroesophageal cancer can include:

  • Unexplained weight loss
  • Abdominal pain
  • Fluid or swelling in the abdomen
  • Reflux
  • Blood in stool
  • Heartburn
  • Indigestion
  • Persistent nausea and/or vomiting
  • Feeling full after a small meal

It’s important to talk to your clinician if you’re having any symptoms of gastroesophageal cancer — especially if you have reflux that happens every day or lasts for a long time.

Over time, acid reflux can cause damage to the lining of the esophagus and increase the risk for cell changes that can lead to cancer.

The good news is that early diagnosis of gastroesophageal cancer can make a big difference in treatment options and outcomes.

The importance of biomarker testing for gastroesophageal cancer

Biomarker testing is key when it comes to treatment for gastroesophageal cancer.

Cancer biomarkers include proteins, genes and substances that can be measured to show details about the cancer, including the most targeted treatments that will be most effective in fighting the cancer — a process called targeted therapy.

The survival rate for people living with advanced gastroesophageal cancer is poor, but research shows targeted therapies can lead to better outcomes.

Targeted therapy also helps preserve healthy cells by avoiding side effects and medications that are unlikely to work.

Read: Biomarkers 101 >>

HER2 biomarker and stomach cancer

When it comes to treating gastroesophageal cancer, one important biomarker to know is human epidermal growth factor receptor 2 (HER2).

HER2 biomarkers are proteins found on the surface of cells that help with cell growth and repair. Cancers with high amounts of HER2 protein or HER2 genes are called HER2-positive and tend to grow and spread quickly to other parts of the body.

Knowing your HER2 status is important when finding the best treatment options for stomach and esophageal cancer. About 1 in 5 cases of stomach cancer are HER2- positive, which means HER2-blocking drugs may be an effective treatment option.

However, not all anti-HER2 treatments are successful for stomach cancer. One reason is the HER2 heterogeneity of stomach cancer, which means that not all the cancer cells are identical in stomach cancer like they are in other types of HER2-positive cancers, like breast cancer. The level of HER2 can also change over time or after treatment.

HER2 testing is routine for advanced gastroesophageal cancer, so it’s important to make sure you are tested for HER2, talk to your clinician about your HER2 test results and discuss how the results may impact your treatment plan.

Read: The New Biomarkers Impacting Cancer Care >>

Treatment options for gastroesophageal cancer

Treatment options for gastroesophageal cancer vary depending on different factors, such as biomarkers, stage of the cancer and location of the tumor.

For people with early-stage or locally advanced gastroesophageal cancer, treatment usually includes some form of surgery to remove the cancer from the area.

For people with advanced metastatic gastroesophageal cancer, treatment plans may include a combination of therapies including:

  • Chemotherapy
  • Radiation therapy
  • Immunotherapy
  • Targeted therapies
  • Esophageal stents

The good news is there are new treatments for advanced gastroesophageal cancer and more on the horizon. In August 2026, the U.S. Food and Drug Administration approved a new HER2 therapy as first-line treatment for people with advanced, HER2-positive gastroesophageal cancer.

When combined with chemotherapy and immunotherapy, these drugs showed improved outcomes compared to people with advanced gastroesophageal cancer who didn’t have the combination of therapies.

Don’t ignore symptoms of gastroesophageal cancer

Gastroesophageal cancers are one of the leading causes of cancer death worldwide.

But knowing the facts, risk factors and symptoms can help you and your clinician recognize the disease in the early stages when it’s most treatable.


This educational resource was created with support from Jazz, a HealthyWomen Corporate Advisory Council member.